2Berkner KL. Expression of heterologous sequences in adenoviral vector. Curr Top Microbiol Immunol, 1992,158:39- 66.
3Manthrope M,Cornefert- jensen F,Hartikka J, et al. Gene therapy by intrmuscular injection of plasmid DNA:studies on firefly luciferase gene expression in mice. Hum Gene Ther, 1993,4:419- 431.
4Steele RJC, Thompson AM, Hall P, et al. The p53 tumour suppressor gene. Br J Surg, 1998,85:1460- 1467.
5Ohashi M, Kanai f, Ueno H, et al. Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo. Gut,1999,44:366- 371.
6Kitadai Y, Yamazaki H, Yasui W, et al. GC factor represses transcription of several growth factor/receptor genes and causes growth inhibition of human gastric carcinoma cell lines. Cell Growth Differ, 1993,4:291- 296.
7Reed JC. Promise and problem of bcl- 2 antisense therapy. J Natl Cancer Inst,1997,89:988- 990.
9Funato T, Kozawa K, Fujimaki S, et al. Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the her- 2/neu(c- erbB- 2)gene.Chemotherapy, 2001,47:297- 303.
10Sakakura C, Hagiwara A, Tsujimoto H, et al. The anti- proliferative defect of proliferating cell nuclear antigen- specific antisense oligonucleotides on human gastric cancer cell lines. Surg Today,1995,25:184- 186.
